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Abstract
The objective of this paper is to provide a detailed evaluation of type 2 diabetes mellitus
research output from 1951-2012, using large-scale data analysis, bibliometric indicators
and density-equalizing mapping. Data were retrieved from the Science Citation Index
Expanded database, one of the seven curated databases within Web of Science. Using
Boolean operators "OR", "AND" and "NOT", a search strategy was developed to estimate
the total number of published items. Only studies with an English abstract were eligible.
Type 1 diabetes and gestational diabetes items were excluded. Specific software devel-
oped for the database analysed the data. Information including titles, authors’ affiliations
and publication years were extracted from all files and exported to excel. Density-equaliz-
ing mapping was conducted as described by Groenberg-Kloft et al, 2008. A total of 24,783
items were published and cited 476,002 times. The greatest number of outputs were pub-
lished in 2010 (n=2,139). The United States contributed 28.8% to the overall output, fol-
lowed by the United Kingdom (8.2%) and Japan (7.7%). Bilateral cooperation was most
common between the United States and United Kingdom (n=237). Harvard University pro-
duced 2% of all publications, followed by the University of California (1.1%). The leading
journals were Diabetes, Diabetologia and Diabetes Care and they contributed 9.3%, 7.3%
and 4.0% of the research yield, respectively. In conclusion, the volume of research is ris-
ing in parallel with the increasing global burden of disease due to type 2 diabetes mellitus.
Bibliometrics analysis provides useful information to scientists and funding agencies
involved in the development and implementation of research strategies to address global
health issues.
Introduction
The burden associated with type 2 diabetes mellitus (T2DM) continues to escalate in developed
and developing countries [1–4]. The global prevalence is expected to rise from 6.4% (285
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million) in 2010 to 7.7% (439 million) in 2030 among adults aged 20–79 years [5]. The eco-
nomic cost of T2DM in the United Kingdom (UK) in 2010/2011 was £8.8 billion for direct
costs and £13 billion for indirect costs, and this is forecasted to increase to £15.1 billion for
direct costs and £20.5 billion for indirect costs by 2035/2036 [6].
Bibliometrics is a useful method to evaluate trends in research activity over time and to
inform future policy. Findings from bibliometrics studies have played a fundamental role in
decision making regarding policy formation and the prioritisation of resources for public
health challenges i.e. the Research Assessment Exercise in the UK [7]. Bibliometrics studies
have also been conducted to examine the trends in medical research output for gastroenterol-
ogy [8], infectious diseases [9, 10], microbiology [11], oncology [12, 13], otolaryngology [14],
respiratory medicine [15], surgery [16] and public health [17–19].
Few bibliometrics studies relating to diabetes exist [20–23]. These previous studies focused
on individual countries including Nigeria, Thailand, Argentina and China. Studies do not exist
relating to the global research output for T2DM only. Given its associated disease burden,
there is a need to conduct a bibliometrics study on the published literature relating to T2DM to
investigate if the increasing global prevalence of this disease is reflected in trends in the litera-
ture. Therefore, the aim of this study was to provide a detailed evaluation of the T2DM
research output from 1951–2012 using a specifically developed software to quantitatively ana-
lyse data from the Web of Science, Science Citation Index Expanded (WOS SCI-Expanded)
database in terms of (1) numbers of published items and citations (2) country specific publica-
tions (3) international collaboration and (4) publications by journals and subject areas.
Materials and Methods
Data were retrieved in February 2013 from the WOS SCI-Expanded database produced by the
Thomson Reuters. This citation database is one of seven databases within the Web of Science
(WOS). It is a multidisciplinary index of the scientific journal literature. This human curated
database indexes over 8,500 journals across 150 disciplines and contains all cited references
from the indexed articles. It provides complete reference data for all publications.
With the use of Boolean operators "OR", "AND" and "NOT", the following search query was
developed to estimate the total number of published items related to type 2 diabetes;
((NIDDM) OR (Maturity-Onset Diabetes) OR (Diabetes Mellitus Noninsulin-Dependent) OR
(Diabetes Mellitus Adult-Onset) OR (Adult-Onset Diabetes Mellitus) OR (Diabetes Mellitus
Adult Onset) OR (Diabetes Mellitus Ketosis-Resistant) OR (Diabetes Mellitus Ketosis Resis-
tant) OR (Ketosis-Resistant Diabetes Mellitus) OR (Diabetes Mellitus Maturity-Onset) OR
(Diabetes Mellitus Maturity Onset) OR (Diabetes Mellitus Non-Insulin Dependent) OR (Dia-
betes Mellitus Non-Insulin-Dependent) OR (Non-Insulin-Dependent Diabetes Mellitus) OR
(Diabetes Mellitus Noninsulin Dependent) OR (Diabetes Mellitus Slow-Onset) OR (Diabetes
Mellitus Slow Onset) OR (Slow-Onset Diabetes Mellitus) OR (Diabetes Mellitus Stable) OR
(Stable Diabetes Mellitus) OR (Diabetes Mellitus Type II) OR (Diabetes Mellitus Type 2) OR
(Maturity-Onset Diabetes Mellitus) OR (Maturity Onset Diabetes Mellitus) OR (MODY) OR
(Type 2 Diabetes Mellitus) OR (Noninsulin-Dependent Diabetes Mellitus)). Published items
that included type 1 diabetes and gestational diabetes were also searched and then excluded
from the analysis (S1 Appendix).
Certain limits were also applied to the search query (S1 Appendix). The time period under
study was 1951–2012. The search was conducted in February 2013 and therefore, 2013 was
eliminated from the analysis as complete data for that year was unavailable. The search
included all document types including original articles, reviews, letters and editorials. All pub-
lished items also had to provide an English abstract to be eligible for the inclusion criteria.
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The results of the search were reviewed once the query was performed. To export all neces-
sary information from all articles, plain text files and full records were selected in the search
results page. The topic of each article was also selected rather than the title as the topic search
also examines the keywords and the abstract too.
Specific software developed by the Charité University in Berlin was used to quantitatively
analyse data from the WOS SCI-Expanded database (S2 Appendix). Once the search criteria
was entered, the data was exported from the database and each data item was downloaded and
contained in a ‘data block’ as text files. All data blocks were tagged and the software separated
the provided information on the content of the block including AU = authors, TI = title,
PY = publication year and AF = affiliation. Initially, the software read each tag and the linked
data and saved it to a Microsoft Access database. The software highlighted any invalid
addresses (usually due to the use of acronyms) and asked the user to identify the correct
addresses. The user then located all of the correct addresses with the use of Google Scholar.
Data on institutions and authors were reviewed using the same method. There was no missing
data regarding addresses, institutions or authors.
The data was then exported to a Microsoft Excel database for descriptive analysis. Published
items were examined using the citation report method [24, 25]. The number of citations per
year and the average number of citations per item were investigated. The average number of
citations per item was calculated based on the number of citations divided by the number of
published items found.
Density equalizing mapping was employed as described by Groeneberg-Kloft et al in 2008
[26]. All countries responsible for publishing the literature were scaled according to different
variables of interest including the number of published items and the average number of cita-
tions per item for each country. Calculations were based on Gaster and Newman's algorithm
[27]. From the concepts of elementary physics, these calculations incorporated a diffusion
equation in the Fourier domain, which enabled variable resolution by tracking moving bound-
aries [27]. Colour coded legends were presented to explain the scaling of the maps. For the
map relating to the average number of citations per item for each country, a threshold excluded
countries with less than 30 published items to improve clarity.
Cooperation analysis was conducted based on the author’s affiliations to examine bilateral
and multilateral cooperation between countries and between institutions on T2DM research.
The cooperation network was developed by examining all combinations of the countries and of
the institutions that registered international cooperation’s on at least 10 items from 1951 to
2012. The data was then saved to a two-dimensional table. From the table, radar charts were
designed and the software created a density-equalising map to illustrate the collaboration
between countries. The subject categories for the published items were also analysed.
The journals that published the items relating to T2DM were investigated according to the
number of published items, number of citations, average number of citations per item, impact
factor and the Eigenfactor scores. The impact factor and Eigenfactor scores were extracted
from the Thomson Reuters Journal Citation Reports (JCR). The impact factor score is calcu-
lated based on the numerator (the number of citations in the current year to items published in
the previous two years) and the denominator (the number of substantive articles and reviews
published in the same two years) [28]. The Eigenfactor endeavours to rate the influence of jour-
nals. The Eigenfactor score is calculated based on a complex algorithm that corresponds to a
model of research where individuals trail a sequence of citations as they move from journal to
journal. The score considers the quantity of citations and their "quality" by assigning weights to
the source of the citations. The Eigenfactor scores are scaled to ensure that the sum of the
scores of all journals listed in the Thomson’s JCR is 100. The impact factor scores were avail-
able for 2012. The Eigenfactor scores were available for 2011 only.
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Results
Publications by year
During the time period 1951–2012, 25,271 items relating to T2DM were published and indexed
in the WOS SCI-Expanded database. A total of 488 published items were excluded before anal-
ysis due to inadequate information i.e. missing data on authors’ affiliations. Overall, 24,783
items were analysed and these items were cited 476,002 times. As expected, a strong correlation
was observed between the number of citations and the number of publications (Fig 1). Studies
relating to T2DM were not recorded in the WOS SCI-Expanded database until 1951 (n = 3).
The frequency of publications started to increase steadily in the late 1980’s (1983, n = 50) (Fig
Fig 1. Distribution of T2DM publications and associated citations in theWOS SCI-Expanded database from 1951–2012 (—total number of
publications,—total number of associated citations).
doi:10.1371/journal.pone.0133009.g001
Type 2 Diabetes Research Output, 1951-2012, Bibliometrics Analysis
PLOS ONE | DOI:10.1371/journal.pone.0133009 July 24, 2015 4 / 14
1) but sharply increased in the 1990’s (1997, n = 1005) (Fig 1). The greatest number of outputs
were published in 2010 (n = 2,139). Articles published in 2002 received more citations
(n = 38,412) than the other years. From 2001–2012, a descending trend was observed for the
average number of citations per item.
Publications by country
A total of 129 countries contributed to the overall published output during the study period.
The United States of America (USA) published the highest number of publications (n = 7,134)
(Table 1). The density equalizing mapping in Fig 2 illustrates that a small number of countries
were accountable for most of the output as the size of each country was scaled in proportion to
the total number of publications. The USA contributed to 28.8% of the overall output, followed
by the United Kingdom (UK) (8.2%), Japan (7.7%) and Germany (6.0%). The USA and the UK
also received the greatest number of citations, respectively (n = 232,431; 67,715). Switzerland
(>45) had the highest citation average per item (47.18) (Fig 3). Denmark, Australia and Can-
ada recorded a citation average greater than 35, while countries like the UK, USA, Sweden and
Finland received an average greater than 30.
Table 1. Leading 25 countries by number of T2DM publications and average citations per item, 1951–2012.
Rank Country No. of publications Received citations Average citations per item*
1 United States 7134 232431 32.58
2 United Kingdom 2031 67715 33.34
3 Japan 1917 30486 15.90
4 Germany 1497 28606 19.11
5 Italy 1359 30793 22.66
6 France 904 23152 25.61
7 Netherlands 826 21342 25.84
8 Canada 796 28355 35.62
9 China 790 7727 9.78
10 Australia 748 28701 38.37
11 Spain 726 10709 14.75
12 Sweden 622 19626 31.55
13 Denmark 535 20884 39.04
14 India 494 4637 9.387
15 Turkey 482 3801 7.89
16 South Korea 408 4902 12.01
17 Brazil 403 3286 8.15
18 Finland 388 11926 30.74
19 Greece 344 4426 12.87
20 Switzerland 315 14862 47.18
21 Taiwan 294 3386 11.52
22 Austria 277 3615 13.05
23 Poland 268 2551 9.52
24 Russia 263 626 2.38
25 Israel 237 5298 22.35
* Average citations per item = number of citations/ number of published items
doi:10.1371/journal.pone.0133009.t001
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International collaboration
Cooperation analysis was conducted to examine the international collaboration observed dur-
ing the time period. International cooperation steadily increased from the early 1990's but the
greatest numbers of cooperations for published items were indexed in 2010, with 367 cooper-
ated items. Bilateral cooperation was the most common type of cooperation (n = 2,325 items),
followed by trilateral cooperation (n = 440) and quadrilateral cooperations (n = 131). Bilateral
cooperation was most frequent between the USA and the UK (n = 237), followed by the USA
and Germany (n = 167) (Fig 4). The USA (n = 14) and the UK (n = 11) contributed to the
majority of these bilateral cooperations (Table 2).
Fig 2. Density equalizingmapping, total output by country. Illustration of the total number of T2DM items,
per country. The size of each country is scaled in proportion to the total number of publications. The colour
coded legend shows the publication numbers.
doi:10.1371/journal.pone.0133009.g002
Fig 3. Density equalizingmapping, average number of citations per T2DM related item by country.
The size of each country is scaled in proportion to the average number of citations per item. The colour coded
legend shows the average number of citations per item. Threshold excludes countries with30 items
published.
doi:10.1371/journal.pone.0133009.g003
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Institutional collaboration
Harvard University in Boston produced 2% of the overall T2DM research output, followed by
the University of California in Los Angeles (1.1%) and the University of London (0.92%). The
majority of institutions collaborated with other institutions within the same country (Fig 5). Of
the 285 articles published by Harvard University, 318 articles were in cooperation with another
institution. Harvard University and the Children's Hospital in Boston created 72 articles in
cooperation and these articles were cited 3491 times during the study period (Fig 5). Interna-
tional institutional collaboration was rare but was most common among the University of Chi-
cago and Tokyo’s Women’s Medical University (n = 1, cited 772 times).
Publications by journal
A total of 2,498 journals published at least one item related to T2DM from 1951–2012. Publica-
tions in this area were most frequent from three leading journals including Diabetes
(n = 2303), Diabetologia (n = 1797) and Diabetes Care (n = 989) as seen in Table 3. These three
journals represented 9.3%, 7.3% and 4.0% of the overall output, respectively. The leading 20
Fig 4. Radar chart of international collaboration density. Threshold10 publications due to international collaborations.
doi:10.1371/journal.pone.0133009.g004
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journals contributed 36.4% of the overall publication output (9031/24783) and the Eigenfactor
scores ranged from 0–0.53 (Table 3).
The ranking of journals differed when the numbers of citations per journal were compared.
Diabetes Care (n = 53,339) received the highest number of citations followed by Diabetes
(n = 40,398), Circulation (n = 17,890) and the New England Journal of Medicine (n = 17,653)
(Fig 6). The New England Journal of Medicine received the greatest average number of cita-
tions per item 232.28 (17653/76) followed by the Journal of the American Medical Association
(JAMA) (n = 169.64), Journal of Clinical Investigation (n = 133.81) and the Lancet
(n = 113.94) (Table 4). The New England Journal of Medicine also reported the highest impact
factor (n = 53.3). The principal subject categories of the extracted journals were ‘Endocrinology
&Metabolism’ (39.6%), ‘Cardiovascular System & Cardiology’ (11.5%) and ‘General & Internal
Medicine’ (11.4%). The Proceedings of the National Academy of Sciences of the USA of Amer-
ica received the highest Eigenfactor score, 1.60 (Table 4).
Discussion
The present study sought to provide a detailed evaluation of the T2DM published literature
using large scale data, bibliometric indicators and density-equalizing mapping. A total of
24,783 items were published and cited 476,002 times over the study period. The huge number
of countries included in T2DM research reflects the global burden of the disease. The density-
equalizing mapping showed that the USA and the UK were responsible for the majority of the
published literature. However, Switzerland received the highest citation average per item. Bilat-
eral cooperation was the most common type of international collaboration and this was princi-
pally observed between two of the dominant countries including the USA and the UK. The
leading research institutions were Harvard University in Boston, the University of California in
Los Angeles and the University of London. The USA and UK also collaborated with other
countries that provided a smaller research yield including Italy and Switzerland. Given the
increasing prevalence of T2DM in some of the Asian countries such as India and China [29] it
is vital that the leading countries make a concerted effort to share their knowledge and
Table 2. Top 15 collaborating relationships, T2DM related items, 1951–2012.
Rank Country 1 Country 2 Published items
1 United Kingdom United States 237
2 Germany United States 167
3 Canada United States 165
4 Italy United States 159
5 France United States 119
6 Germany United Kingdom 110
7 Sweden United States 106
8 France United Kingdom 105
9 Japan United States 101
10 Netherlands United States 100
11 Australia United States 93
11 China United States 93
12 Australia United Kingdom 92
13 Italy United Kingdom 87
14 Denmark United States 83
15 Switzerland United States 76
doi:10.1371/journal.pone.0133009.t002
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Fig 5. Radar chart of institutional collaboration density. Threshold50 published items and >10 collaborations.
doi:10.1371/journal.pone.0133009.g005
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collaborate with these countries in future research initiatives, particularly concentrating on the
management and treatment strategies for T2DM.
The quality of the research output was measured based on the average citation rate (average
number of citations per item), the impact factor scores and the Eigenfactor scores. Diabetes
focused journals including Diabetes, Diabetologia and Diabetes Care mainly contributed to the
publication output while the New England Journal of Medicine had the highest average number
of citations per item and the greatest impact factor score. The highest Eigenfactor score was
awarded to the Proceedings of the National Academy of Sciences of the United States of America.
In comparison with the findings of previous studies, our results showed that research output
escalated in the late 1980's, 1990's and 2000's in addition to the citation count showing the
enhanced interest in T2DM research [20–23]. Specifically, articles published in 2002 received
more citations (n = 38,412) than other years suggesting that there may have been more funding
opportunities for research in this area given the increasing prevalence of T2DM.
The increasing research output mirrored the growing prevalence of T2DM [1]. A downward
trend from 2001–2012 showed that the average number of citations per item was falling during
this time perhaps due to the influx of additional published items or the citation lag associated
with publications in some disease specific areas.
Strengths of this study include the use of the extensive WOS SCI-Expanded database. The
database provided complete references of published items for the analysis. While PubMed
would have offered similar numbers of published items, the reference data would have been
incomplete. As the average number of citations per item may have been overestimated as a
result of self-citation, the current study also included the impact factor and Eigenfactor scores
to compare the quality of publishing journals.
Table 3. Leading 20 journals by T2DM-related published items.
Rank Name Published items Citations Impact factor Eigenfactor
1 DIABETES 2303 40398 8.29 0.10
2 DIABETOLOGIA 1797 9977 6.84 0.06
3 DIABETES CARE 989 53339 8.09 0.11
4 DIABETES RES CLIN PR 481 4707 2.75 0.16
5 DIABETIC MED 408 7871 2.90 0.02
6 METABOLISM 286 4599 2.66 0.02
7 CIRCULATION 286 17890 14.74 0.34
8 J CLIN ENDOCR METAB 247 10278 5.97 0.13
9 J HYPERTENS 200 2705 4.02 0.03
10 VALUE HEALTH 184 102 2.19 0.01
11 DIABETES OBES METAB 178 1982 3.38 0.01
12 ATHEROSCLEROSIS 163 2200 3.79 0.05
13 AM J CARDIOL 155 3497 3.37 0.08
14 INT J OBESITY 135 3248 4.69 0.04
15 J AM COLL CARDIOL 131 2953 14.16 0.22
16 LANCET 122 13901 38.28 0.36
17 CLIN RES CARDIOL 120 67 2.95 0.00
18 J DIABETES COMPLICAT 114 1386 2.03 0.00
19 EUR HEART J 113 1290 10.48 0.11
20 HORM METAB RES 106 1701 2.19 0.01
Impact factor and Eigenfactor scores from Thomson Reuters JCR.
doi:10.1371/journal.pone.0133009.t003
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There are a number of limitations to this study. The specifically developed software was an
output trending and collaboration tool that was specifically designed for the WOS SCI-Ex-
panded database so only data entries exported from this database were included in the analysis.
The WOS SCI-Expanded database has access to the first available publications with archived
records and would have provided a comprehensive summary of research productivity trends
during the study period. The addition of the other six databases within WOS and the inclusion
of databases like Scopus and PubMed would have provided a higher volume of published items
and different results. For citation analysis, Scopus offers about 20% more coverage than the
WOS but the WOS provides more detailed information regarding citations before 1996 [30].
Distinct from Pubmed, WOS tracks citations and has more complete data per published item
i.e. authors affiliations. Author affiliations are recorded and specific information like the
authors’ main organisation name, sub-organisation name(s), city, state, zone numbers and
countries are documented. It would not have been possible to investigate international and
institutional collaborations with Pubmed.
Fig 6. Leading 15 journals by T2DM-related published items and number of received citations, 1951–2012.
doi:10.1371/journal.pone.0133009.g006
Type 2 Diabetes Research Output, 1951-2012, Bibliometrics Analysis
PLOS ONE | DOI:10.1371/journal.pone.0133009 July 24, 2015 11 / 14
The search strategy may have omitted some suitable T2DM articles if the keywords,
abstracts or titles of articles mentioned type 1 diabetes or gestational diabetes as all published
items that focused on type 1 diabetes and gestational diabetes were excluded. In addition, some
important articles may have been excluded from the analysis if the article was published in a
language other than English. For example, the contribution from some countries like China
and India to the body of literature was small relative to their populations. Given that transla-
tion costs may be expensive, this issue may have affected the contributions from other coun-
tries. Although this study examined the T2DM publications trends by year, country and
journal, it did not investigate variables that may be associated with the output like socio-demo-
graphic and economic characteristics. This study will however contribute to the evidence base
and facilitate the conduction of such studies in T2DM research. This is the first study to pro-
vide an overview of the published literature on T2DM using specifically designed software to
analyse large scale data, bibliometric approaches and density-equalizing mapping.
Conclusion
There is a rapidly growing volume of research in T2DM in parallel with the increasing prevalence
of this condition globally. However, research outputs remain highly concentrated in a small num-
ber of developed countries. This has implications for research priorities globally and it is neces-
sary to find an optimum balance between basic and applied research. There is a clear need to
promote a deeper engagement through collaboration and funding mechanisms. Although the
bibliometric methodology employed here has some limitations regarding the small volume of
published items, we believe that these findings offer useful information to scientists and funding
bodies regarding publication trends and ongoing collaborative work in T2DM research.
Table 4. Top 20 journals by average citations per T2DM item.
Rank Name Average citations per item* Citations Published items Impact factor Eigenfactor
1 N ENGL J MED 232.28 17653 76 53.3 0.66
2 JAMA-J AM MED ASSOC 169.64 12723 75 30.03 0.29
3 J CLIN INVEST 133.81 7092 53 13.07 0.22
4 LANCET 113.94 13901 122 38.28 0.36
5 HYPERTENSION 98.28 6683 68 6.21 0.07
6 P NATL ACAD SCI USA 91.65 3391 37 9.68 1.60
7 CIRCULATION 62.55 17890 286 14.74 0.34
8 GASTROENTEROLOGY 61.07 2687 44 11.68 0.16
9 DIABETES CARE 53.93 53339 989 8.09 0.11
10 TRENDS ENDOCRIN MET 53.83 1615 30 8.12 0.02
11 AM J KIDNEY DIS 50.84 2593 51 5.43 0.04
12 HEPATOLOGY 49.06 1570 32 11.67 0.12
13 ENDOCRINOLOGY 45.79 1786 39 4.46 0.09
14 ARCH INTERN MED 45.27 4165 92 11.46 0.12
15 AM J CLIN NUTR 45.01 4051 90 6.67 0.09
16 AM J EPIDEMIOL 42.88 1372 32 5.22 0.07
17 J CLIN ENDOCR METAB 41.61 10278 247 5.97 0.13
18 ARTERIOSCL THROM VAS 41.15 2798 68 6.37 0.08
19 ANN INTERN MED 41.09 3534 86 16.73 0.12
20 OBESITY 37.56 2404 64 4.28 0.05
* Average citations per item = Number of citations/ number of published items. Impact factor and Eigenfactor scores from Thomson Reuters JCR
doi:10.1371/journal.pone.0133009.t004
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